Organization
Division 4 of Pulmonary Oncology, Cancer Center
1 abstract
Abstract
Prospective dynamic sampling and molecular residual disease monitoring to predict clinical outcomes for patients with unresectable, locally advanced non-small cell lung cancer undergoing radical radiotherapy.Org: Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China, Southern Medical University, Geneplus-Beijing, Beijing, China, Geneplus-Beijing Institute,